Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
RARE

Ultragenyx

07:06
08/20/18
08/20
07:06
08/20/18
07:06
Recommendations
Ultragenyx analyst commentary at SunTrust »

Ultragenyx price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

  • 12

    Sep

Thursday
EXEL

Exelixis

$19.42

-0.47 (-2.36%)

04:55
08/16/18
08/16
04:55
08/16/18
04:55
Conference/Events
Exelixis management to meet with Oppenheimer »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 12

    Sep

  • 14

    Jan

Wednesday
GILD

Gilead

$74.82

-2.5 (-3.23%)

, GSK

GlaxoSmithKline

$40.53

0.74 (1.86%)

14:02
08/15/18
08/15
14:02
08/15/18
14:02
Recommendations
Gilead, GlaxoSmithKline analyst commentary at RBC Capital »

RBC says Gilead weakness…

GILD

Gilead

$74.82

-2.5 (-3.23%)

GSK

GlaxoSmithKline

$40.53

0.74 (1.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 25

    Aug

  • 30

    Aug

  • 31

    Aug

CLVS

Clovis

$35.20

0.645 (1.87%)

11:00
08/15/18
08/15
11:00
08/15/18
11:00
Options
Notable call spread in Clovis Oncology as shares see strength »

Notable call spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GILD

Gilead

$77.32

0.14 (0.18%)

08:57
08/15/18
08/15
08:57
08/15/18
08:57
Recommendations
Gilead analyst commentary at RBC Capital »

Gilead priority review…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Aug

  • 31

    Aug

ESRX

Express Scripts

$86.05

2.01 (2.39%)

, BMRN

BioMarin

$103.17

0.46 (0.45%)

07:46
08/15/18
08/15
07:46
08/15/18
07:46
Periodicals
Express Scripts in talks with biotechs for hemophilia therapies, Reuters reports »

Express Scripts (ESRX) is…

ESRX

Express Scripts

$86.05

2.01 (2.39%)

BMRN

BioMarin

$103.17

0.46 (0.45%)

ONCE

Spark Therapeutics

$61.35

2.84 (4.85%)

BLUE

Bluebird Bio

$156.25

0.2 (0.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 10

    Sep

  • 12

    Sep

  • 01

    Dec

Over a week ago
GILD

Gilead

$77.32

0.14 (0.18%)

17:02
08/14/18
08/14
17:02
08/14/18
17:02
Hot Stocks
Gilead announces management changes and appointments »

Gilead Sciences announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Aug

  • 31

    Aug

EXEL

Exelixis

$19.90

0.26 (1.32%)

11:10
08/14/18
08/14
11:10
08/14/18
11:10
Conference/Events
Exelixis management to meet with Oppenheimer »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 14

    Jan

PTLA

Portola Pharmaceuticals

$30.74

-7.03 (-18.61%)

07:38
08/10/18
08/10
07:38
08/10/18
07:38
Recommendations
Portola Pharmaceuticals analyst commentary at Citi »

Portola Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Aug

PTLA

Portola Pharmaceuticals

$30.74

-7.03 (-18.61%)

07:10
08/10/18
08/10
07:10
08/10/18
07:10
Recommendations
Portola Pharmaceuticals analyst commentary at Oppenheimer »

Portola Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.